Page last updated: 2024-08-21

naphthazarin and Leukemia, Lymphocytic, Chronic, B-Cell

naphthazarin has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alumkal, JJ; Bicocca, VT; Chang, BH; Chow, M; Gao, L; MacManiman, JD; Tyner, JW	1

Other Studies

1 other study(ies) available for naphthazarin and Leukemia, Lymphocytic, Chronic, B-Cell

Article	Year
Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL. Oncogene, 2018, Volume: 37, Issue:38 Topics: CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Targeted Therapy; Naphthoquinones; Receptor Tyrosine Kinase-like Orphan Receptors; Ubiquitin-Protein Ligases	2018

Article

Year

Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL.

Oncogene, 2018, Volume: 37, Issue:38

Topics: CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Targeted Therapy; Naphthoquinones; Receptor Tyrosine Kinase-like Orphan Receptors; Ubiquitin-Protein Ligases

2018